Rules 4.7.3 and 4.10.3 ASX Listing Rules Appendix 4G (current at 17/7/2020) Page 1 Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Name of entity CYNATA THERAPEUTICS LIMITED ABN/ARBN Financial year ended: 98 104 037 372 30 JUNE 2026 Our corporate...
Appendix 4G
Filed with ASX ·
On 6ix: 6ix.com/news/appendix-4g-118
6ix hasn’t read this filing yet.
Cynata Therapeutics Limited on 6ix
Earlier from Cynata Therapeutics
- Corporate Governance Statement
- Annual Report
- Notification under Listing Rule 4.3D
- Notification of cessation of securities - CYP
- Appendix 4E & Preliminary Final Report
Later from Cynata Therapeutics
- Date of AGM and Closing Date for Director Nominations
- R&D Tax Incentive Loan Facility Extension
- Cynata Receives R&D TI Refund & Repays R&D TI Loan
- Termination of At-the-Market Subscription Deed
- Entitlement Offer & Unmarketable Parcel Sale Facility
Follow Cynata Therapeutics into a list and get an email when it puts out news.
Follow Cynata Therapeutics